Advertisement

Topics

Azur Pharma Limited Company Profile

16:42 EDT 19th September 2017 | BioPortfolio

Azur Pharma is a privately held therapeutically focused pharmaceutical company, headquartered in Dublin, Ireland.We are dedicated to enhancing patient's lives by developing and marketing pharmaceutical products in focused therapeutic areas.Our mission is to create a therapeutically focused pharmaceutical business, sustained through a marketed product portfolio and a product pipeline.Our strategy is to identify, evaluate, selectively acquire and enhance the value of FDA approved, and late-stage development, pharmaceutical assets.Our management team has multiple years of operational, commercial and corporate development experience in the pharmaceutical industry and has developed broad industry relationships.

Location

45 Fitzwilliam Square
Dublin 2
Ireland

Contact

Phone: 353-1-6344-183
Fax: 353-1-6344-170


News Articles [2311 Associated News Articles listed on BioPortfolio]

Wildfires force French Riviera evacuations

French authorities ordered the evacuation of up to 12,000 people around a picturesque hilltop town in the southern Côte d’Azur region as fires hopscotched around the Mediterranean coast for a third...

Chikungunya – France

Local transmission of chikungunya has been confirmed in south eastern France, with four cases diagnosed in the Provence-Alpes-Côte d'Azur region as of 23 August 2017. In addition, there is one probab...

Fosun Pharma, Shanghai Pharma Bid for Arbor Pharma, Deal May Fetch $700 Million

  Life Sciences Jobs   ...

CEO of LEO Pharma on how they are driving collaborations

Précis: Gitte Aabo, CEO, LEO Pharma speaking at eyeforpharma Barcelona on what LEO Pharma are doing to drive collaborations and create more value for patients and healthcare.YouTube URL: ht...

Verona Pharma plc: Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for...

Verona Pharma plc: Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA

June 5, 2017, LONDON - Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics f...

#jobs #lifescience Assistant Controller – Pharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Assistant Controller – Pharma .NJ-Fort Lee, RESPONSIBILITIES: Kforce...

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Drugs and Medications [288 Associated Drugs and Medications listed on BioPortfolio]

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Gesticare dha [Azur Pharma, Inc.]

Gesticare® DHA Prenatal Multi-vitamin/Mineral Tablets with DHA and Choline

Urelle [Azur Pharma Inc.]

Urelle Urinary Antiseptic

Ranitidine [WOCKHARDT LIMITED]

PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Enhancement of sorption capacity of cocoa shell biomass modified with non-thermal plasma for removal of both cationic and anionic dyes from aqueous solution.

Removal of cationic dye, Azur II, and anionic dye, Reactive Red 2 (RR-2) from aqueous solutions, has been successfully achieved by using a modified agricultural biomaterial waste: cocoa shell husk (Th...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [795 Associated Companies listed on BioPortfolio]

Azur Pharma Ltd.

Azur is a privately held pharmaceutical company dedicated to enhancing patients' lives by developing and marketing pharmaceutical products in specialist therapeutic areas. Azur's strategy is to id...

Azur Pharma Limited

Azur Pharma is a privately held therapeutically focused pharmaceutical company, headquartered in Dublin, Ireland.We are dedicated to enhancing patient's lives by developing and marketing pharmaceutica...

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "Azur Pharma Limited" on BioPortfolio

We have published hundreds of Azur Pharma Limited news stories on BioPortfolio along with dozens of Azur Pharma Limited Clinical Trials and PubMed Articles about Azur Pharma Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Azur Pharma Limited Companies in our database. You can also find out about relevant Azur Pharma Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record